VICTORIA LAFAZIA: Open Payments
NPI 1104557297 · EAST GREENWICH, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,309 in 123 payments from 28 companies in 2025. Trend: 2023 $2,514 · 2024 $3,254 · 2025 $2,309
Food & beverage: $2,309
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $371 |
| PFIZER INC. | 21 | $251 |
| Novo Nordisk Inc | 9 | $213 |
| AstraZeneca Pharmaceuticals LP | 10 | $210 |
| GlaxoSmithKline, LLC. | 8 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $130 |
| Janssen Biotech, Inc. | 4 | $126 |
| Inspire Medical Systems, Inc. | 5 | $117 |
| TOLMAR, INC. | 5 | $103 |
| Lilly USA, LLC | 4 | $93 |
Products named: JARDIANCE, UBRELVY, QULIPTA, INSPIRE, NURTEC ODT, JATENZO, EPKINLY, ERLEADA.
Industry payments across RI — which companies pay providers there.
